You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
嘉應制藥(002198.SZ):2019年度計提商譽及資產減值1.2億元-1.4億元 預虧1.13億元–1.42億元
格隆匯 01-22 17:49

格隆匯1月22日丨嘉應制藥(002198.SZ)披露2019年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨虧損1.13億元–1.42億元,上年同期盈利3581萬元。業績變動原因如下:

1、2019年醫藥行業競爭加劇,公司為維護現有的市場份額,並進一步推廣高附加值的產品,在市場調研、銷售拓展、臨牀指導、招投標售後服務等方面的投入增加較大。同時因公司在GMP到期認證前數個月進行車間停產改造,期間管理費用增加,部分產品市場斷貨,產品銷售量同比下滑,導致公司2019年主營業務經營業績下降。

2、子公司金沙藥業受醫藥行業“4+7”、兩票制及集中採購、醫保控費、流通整治等一系列政策的影響較大,預計2019年淨利潤同比下降約50%,導致併購金沙藥業時產生的合併報表商譽出現減值跡象。經公司初步測算,預計商譽及其所在的資產組減值範圍在1.2億元-1.4億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account